{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T08:10:08Z","timestamp":1732435808774,"version":"3.28.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,23]]},"DOI":"10.7759\/cureus.74330","type":"journal-article","created":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T07:46:31Z","timestamp":1732434391000},"source":"Crossref","is-referenced-by-count":0,"title":["Hepatocellular Carcinoma Developing in a Patient 29 Years After Achieving Sustained Virologic Response for Hepatitis C With Interferon Therapy: A Case Report"],"prefix":"10.7759","author":[{"given":"Yosuke","family":"Maezawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ariga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Kashimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Irie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X10385964","article-title":"Surveillance for hepatocellular carcinoma: in whom and how?","volume":"4","author":"El-Serag HB","year":"2011","unstructured":"El-Serag HB, Davila JA. Surveillance for hepatocellular carcinoma: in whom and how?. Therap Adv Gastroenterol. 2011, 4:5-10. 10.1177\/1756283X10385964","journal-title":"Therap Adv Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag HB","year":"2012","unstructured":"El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012, 142:1264-73. 10.1053\/j.gastro.2011.12.061","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26371","article-title":"New horizons in hepatitis C antiviral therapy with direct-acting antivirals","volume":"58","author":"Aghemo A","year":"2013","unstructured":"Aghemo A, De Francesco R. New horizons in hepatitis C antiviral therapy with direct-acting antivirals. Hepatology. 2013, 58:428-38. 10.1002\/hep.26371","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-019-00255-4","article-title":"Hepatocellular carcinoma surveillance in a cohort of chronic hepatitis C virus-infected patients with cirrhosis","volume":"51","author":"Abara WE","year":"2020","unstructured":"Abara WE, Spradling P, Zhong Y, et al.. Hepatocellular carcinoma surveillance in a cohort of chronic hepatitis C virus-infected patients with cirrhosis. J Gastrointest Cancer. 2020, 51:461-8. 10.1007\/s12029-019-00255-4","journal-title":"J Gastrointest Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.46.1586","article-title":"Development of hepatocellular carcinoma (HCC) in a patient 17 years after recovery from chronic hepatitis B and seroconversion to anti-HBs","volume":"46","author":"Shigematsu S","year":"2007","unstructured":"Shigematsu S, Kumagi T, Hiasa Y, et al.. Development of hepatocellular carcinoma (HCC) in a patient 17 years after recovery from chronic hepatitis B and seroconversion to anti-HBs. Intern Med. 2007, 46:29-33. 10.2169\/internalmedicine.46.1586","journal-title":"Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20073","article-title":"Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data","volume":"39","author":"Camm\u00e0 C","year":"2004","unstructured":"Camm\u00e0 C, Di Bona D, Schepis F, et al.. Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data. Hepatology. 2004, 39:333-42. 10.1002\/hep.20073","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22694","article-title":"Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients","volume":"49","author":"George SL","year":"2009","unstructured":"George SL, Bacon BR, Brunt EM, Mihindukulasuriya KL, Hoffmann J, Di Bisceglie AM. Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients. Hepatology. 2009, 49:729-38. 10.1002\/hep.22694","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33023","article-title":"Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C","volume":"122","author":"Poynard T","year":"2002","unstructured":"Poynard T, McHutchison J, Manns M, et al.. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology. 2002, 122:1303-13. 10.1053\/gast.2002.33023","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23744","article-title":"Outcome of sustained virological responders with histologically advanced chronic hepatitis C","volume":"52","author":"Morgan TR","year":"2010","unstructured":"Morgan TR, Ghany MG, Kim HY, et al.. Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology. 2010, 52:833-44. 10.1002\/hep.23744","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20537","article-title":"Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy","volume":"101","author":"Makiyama A","year":"2004","unstructured":"Makiyama A, Itoh Y, Kasahara A, et al.. Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. Cancer. 2004, 101:1616-22. 10.1002\/cncr.20537","journal-title":"Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26087","article-title":"Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C","volume":"57","author":"Arase Y","year":"2013","unstructured":"Arase Y, Kobayashi M, Suzuki F, et al.. Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C. Hepatology. 2013, 57:964-73. 10.1002\/hep.26087","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.07.024","article-title":"Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C","volume":"69","author":"Ioannou GN","year":"2018","unstructured":"Ioannou GN, Green PK, Beste LA, Mun EJ, Kerr KF, Berry K. Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C. J Hepatol. 2018, 69:1088-98. 10.1016\/j.jhep.2018.07.024","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13310","article-title":"Incidence and risk factors of hepatocellular carcinoma change over time in patients with hepatitis C virus infection who achieved sustained virologic response","volume":"49","author":"Yamada R","year":"2019","unstructured":"Yamada R, Hiramatsu N, Oze T, et al.. Incidence and risk factors of hepatocellular carcinoma change over time in patients with hepatitis C virus infection who achieved sustained virologic response. Hepatol Res. 2019, 49:570-8. 10.1111\/hepr.13310","journal-title":"Hepatol Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.07.025","article-title":"Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression","volume":"67","author":"Waziry R","year":"2017","unstructured":"Waziry R, Hajarizadeh B, Grebely J, et al.. Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression. J Hepatol. 2017, 67:1204-12. 10.1016\/j.jhep.2017.07.025","journal-title":"J Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12393","article-title":"Suppression of hepatocellular carcinoma development in hepatitis C patients given interferon-based antiviral therapy","volume":"45","author":"Hiramatsu N","year":"2015","unstructured":"Hiramatsu N, Oze T, Takehara T. Suppression of hepatocellular carcinoma development in hepatitis C patients given interferon-based antiviral therapy. Hepatol Res. 2015, 45:152-61. 10.1111\/hepr.12393","journal-title":"Hepatol Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-013-0921-z","article-title":"Hepatocarcinogenesis in chronic hepatitis C patients achieving a sustained virological response to interferon: significance of lifelong periodic cancer screening for improving outcomes","volume":"49","author":"Yamashita N","year":"2014","unstructured":"Yamashita N, Ohho A, Yamasaki A, Kurokawa M, Kotoh K, Kajiwara E. Hepatocarcinogenesis in chronic hepatitis C patients achieving a sustained virological response to interferon: significance of lifelong periodic cancer screening for improving outcomes. J Gastroenterol. 2014, 49:1504-13. 10.1007\/s00535-013-0921-z","journal-title":"J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/319319-hepatocellular-carcinoma-developing-in-a-patient-29-years-after-achieving-sustained-virologic-response-for-hepatitis-c-with-interferon-therapy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T07:46:38Z","timestamp":1732434398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/319319-hepatocellular-carcinoma-developing-in-a-patient-29-years-after-achieving-sustained-virologic-response-for-hepatitis-c-with-interferon-therapy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,23]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.74330","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,23]]}}}